Clevair

CLEVAIR-HTA helps pharmaceutical teams move from document hunting to decision-ready evidence. Our agentic-AI platform automates the intake and structuring of key regulatory sources—EU/US clinical trials, product SmPCs, CHMP and other agency opinions, and published HTA evaluations—then organizes them around the PICO framework (Population, Intervention, Comparators, Outcomes). Teams use CLEVAIR-HTA to compare therapeutic options, highlight evidence gaps, and generate reviewer-ready summaries to accelerate HTA dossiers, pricing, and reimbursement submissions. What we deliver • Automated evidence collection and normalization across EU/US sources • PICO-structured comparisons and living evidence tables • Draft syntheses that are consistent, auditable, and ready for expert review • Modules for EU HTA readiness and responsible AI implementation Who we serve Market Access, Regulatory, Medical, and HEOR teams—especially within small and mid-sized pharma organizations that need speed, traceability, and repeatability. Why now With common clinical assessments ramping in the EU and growing expectations for transparency and governance, organizations need tooling that reduces manual effort while strengthening compliance. How we work CLEVAIR-HTA is delivered as SaaS with onboarding, training, and optional services. We also provide in-company seminars and e-learning for AI in healthcare and EU HTA compliance. Interested in a demo or pilot? Use the “Contact us” button or reach us.